Skip to main content
Emily (Stamell) Ruiz, MD, Dermatology, Boston, MA

Emily Stamell (Stamell) Ruiz MD

Dermatology•Boston, MA

Physician

Join to view full profile

  • 450 Brookline AveBoston, MA 02215

  • Phone+1 617-732-5500

Dr. Ruiz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Ruiz's full profileAlready have an account?

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Dermatology, 2011 - 2014
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Internal Medicine, 2010 - 2011
  • New York University School of Medicine
    New York University School of MedicineClass of 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2027
  • NY State Medical License
    NY State Medical License 2011 - 2015
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
  • CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017

Publications & Presentations

PubMed

Lectures

  • High Yield ""Power Hour"" for Residents 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
  • National cancer expenditure analysis in the United States Medicare population, 2013. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Sun Pharmaceutical’s Updated Label for Unloxcyt Receives US FDA Approval
    Sun Pharmaceutical’s Updated Label for Unloxcyt Receives US FDA ApprovalNovember 28th, 2025
  • AI-Derived Risk Score May Improve Risk Stratification of Squamous Cell Carcinomas
    AI-Derived Risk Score May Improve Risk Stratification of Squamous Cell CarcinomasJune 26th, 2025
  • Non-Melanoma Skin Cancer Experts Launch riSCC, a Clinician-Focused Mobile and Web App That Assesses the Risk of Recurrence of Cutaneous Squamous Cell Carcinoma
    Non-Melanoma Skin Cancer Experts Launch riSCC, a Clinician-Focused Mobile and Web App That Assesses the Risk of Recurrence of Cutaneous Squamous Cell CarcinomaMarch 25th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Emily Ruiz, Dr. Emily Ruiz, MD, Dr. E Ruiz, Dr. Emily Stamell Ruiz